This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chan, W-M Articles by Chan, C K M Search for Related Content PubMed PubMed Citation Articles by Chan, W-M Articles by Chan, C K M

Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level

¹ Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong Eye Hospital, Kowloon, Hong Kong, People’s Republic of China
² Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong, People’s Republic of China

Correspondence to:
Correspondence to:
Dr Wai-Man Chan
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, 3/F, Hong Kong Eye Hospital, 147K Argyle Street, Kowloon, Hong Kong; cwm6373{at}netvigator.com

ABSTRACT
Aims: To evaluate the changes in the choroidal vasculature in central serous chorioretinopathy (CSC) after photodynamic therapy (PDT) with verteporfin and to assess its potential role as a treatment option.

Methods: A prospective, non-comparative, interventional study was performed in eyes with persistent CSC or chronic CSC that had fluorescein leakage at the fovea. All eyes received one single session of PDT with verteporfin (6 mg/m² body surface area) followed by application of 50 J/cm² laser at 689 nm. The laser spot size was guided by findings in ICG-A.

Results: Six eyes from six patients with a mean follow up of 12.7 months were analysed. Narrowing of the original dilated choroidal vessels and decrease in extravascular leakage could be demonstrated in all (100%) PDT treated eyes. 3 months after PDT, the mean diameter of the dilated choroidal vessel reduced from 546 µm to 371 µm (p = 0.028). Five (83%) patients had improvement in visual symptoms and best corrected visual acuity. Fluorescence leakage stopped at the 1 month follow up in five eyes (83%) and at 3 months in all six eyes (100%). One eye developed choroidal neovascularisation at 3 month follow up. There was no other serious ocular or systemic complication.

Conclusions: PDT is successful in stopping the fluorescein leakage in all six patients without recurrence of CSC. The ICG-A findings of choroidal vascular remodelling and decreased choroidal permeability after PDT are encouraging. As the sample size is small and the mean follow up period is short, further trials of PDT with verteporfin for CSC are required to address the optimal parameters in ensuring longer term safety and efficacy outcome.

Keywords: choroidal vascular remodelling; indocyanine green; photodynamic therapy; central serous chorioretinopathy

This article has been cited by other articles:

				J M Stewart Half dose verteporfin PDT for central serous chorioretinopathy Br. J. Ophthalmol., July 1, 2006; 90(7): 805 - 806. [Full Text] [PDF]

				T Y Y Lai, W-M Chan, H Li, R Y K Lai, D T L Liu, and D S C Lam Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study Br. J. Ophthalmol., July 1, 2006; 90(7): 869 - 874. [Abstract] [Full Text] [PDF]

				M E J van Velthoven, F D Verbraak, P M Garcia, R O Schlingemann, R B Rosen, and M D de Smet Evaluation of central serous retinopathy with en face optical coherence tomography Br. J. Ophthalmol., November 1, 2005; 89(11): 1483 - 1488. [Abstract] [Full Text] [PDF]